Stock
Stock

Sol-Gel Technologies

15.14

Delay
0
Open
15.25
Market Cap
43.01M+
High
15.70
Low
15.14
Close
15.44
Volume
11.94K+
P/E Ratio
-4.06
Div/Yield
0.00%
Track The Stock Movement

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., una compañía farmacéutica especializada en etapa clínica, se enfoca en desarrollar y comercializar productos farmacéuticos dermatológicos tópicos basados en su sistema patentado de administración de microencapsulación en Israel. Los principales productos candidatos de la empresa incluyen Twyneo, una novedosa crema tópica sin antibióticos que se administra una vez al día y que ha completado los ensayos clínicos de Fase III para el tratamiento del acné vulgar; Epsolay, una crema tópica de una vez al día que ha completado los ensayos clínicos de Fase III para el tratamiento de la rosácea papulopustular; SGT-210, que se encuentra en fase I de ensayo clínico para el tratamiento de la queratodermia palmoplantar; y erlotinib, tapinarof y roflumilast para tratar la psoriasis y otras afecciones médicas. También participa en el desarrollo de medicamentos dermatológicos tópicos genéricos. La empresa cuenta con la colaboración de Perrigo. Sol-Gel Technologies Ltd. se incorporó en 1997 y tiene su sede en Ness Ziona, Israel.

Trade GPT

logo

Company

Social

Download

google playapp store

© 2025 Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.

Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.